InvestSMART

Pharmaxis Ltd (ASX: PXS) - Announcements

- Current share price for PXS : $0.027

ASX company news and announcements for Pharmaxis Ltd (PXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pharmaxis Ltd (PXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pharmaxis Ltd (PXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pharmaxis Ltd (PXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 4 Oct 2016 4:18PM $0.270 $0.027 fallen by 90%
- Change in substantial holding 29 Sep 2016 6:54PM $0.270 $0.027 fallen by 90%
- Appendix 3B - Exercise of Employee Options 27 Sep 2016 4:28PM $0.275 $0.027 fallen by 90.18%
- Pharmaxis Announces Russian Approval for Bronchitol 27 Sep 2016 8:31AM $0.265 $0.027 fallen by 89.81%
- Investor presentation - 6 September 2016 6 Sep 2016 9:37AM $0.285 $0.027 fallen by 90.53%
- Preliminary Final Report 19 Aug 2016 8:40AM $0.320 $0.027 fallen by 91.56%
- Change of Director's Interest Notice - M McComas 15 Aug 2016 8:47AM $0.335 $0.027 fallen by 91.94%
- Pharmaxis presentation at Bioshares 2016 Biotech Summit 29 Jul 2016 8:25AM $0.300 $0.027 fallen by 91%
- Pharmaxis Quarterly Shareholder Update - June 2016 29 Jul 2016 8:22AM $0.300 $0.027 fallen by 91%
- Appendix 4C - quarterly 29 Jul 2016 8:22AM $0.300 $0.027 fallen by 91%
- Proposed Issue of Securities to Chief Executive Officer 26 Jul 2016 8:28AM $0.290 $0.027 fallen by 90.69%
- Appendix 3B - issue of employee options and shares 26 Jul 2016 8:19AM $0.290 $0.027 fallen by 90.69%
- Pharmaxis Completes Recruitment of CF Clinical Trial for US 15 Jul 2016 8:29AM $0.265 $0.027 fallen by 89.81%
- BIO 2016 - Shareholder Update 21 Jun 2016 8:28AM $0.255 $0.027 fallen by 89.41%
- Investor presentation 9 June 2016 9 Jun 2016 4:53PM $0.260 $0.027 fallen by 89.62%
- Corporate Governance Statement 4 May 2016 8:34AM $0.280 $0.027 fallen by 90.36%
- Completion of Unmarketable Parcel Share Sale Facility 4 May 2016 8:32AM $0.280 $0.027 fallen by 90.36%
- Appendix 4C - quarterly March 2016 14 Apr 2016 4:13PM $0.260 $0.027 fallen by 89.62%
- Quarterly Shareholder Update - March 2016 14 Apr 2016 4:11PM $0.260 $0.027 fallen by 89.62%
- Synairgen Collaboration Progress 23 Mar 2016 8:39AM $0.230 $0.027 fallen by 88.26%
- Updated Investor Presentation 14 Mar 2016 9:06AM $0.250 $0.027 fallen by 89.20%
- Becoming a substantial holder from AEF 26 Feb 2016 3:20PM $0.255 $0.027 fallen by 89.41%
- Establishment of Unmarketable Parcel Sale Facility 26 Feb 2016 9:12AM $0.270 $0.027 fallen by 90%
- Half Yearly Report and Accounts 26 Feb 2016 8:22AM $0.270 $0.027 fallen by 90%
- Quarterly Share Update - December 2015 29 Jan 2016 10:13AM $0.320 $0.027 fallen by 91.56%

526 - 550 of 836 results

Page 22 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.